02 Nov |
Receipt of a favourable Commission Implementing Decision from the European Commission on the proposed transfer of the European Marketing Authorisation of Fortacin™ to Recordati |
N/A |
23 Oct |
Receipt of €4 million from Recordati in respect of the Amended and Restated Licence Agreement becoming effective (on 3 October 2017) |
N/A |
03 Oct |
Execution of: (i) the Amended and Restated Licence Agreement with Recordati; and (ii) the Amended Development, Manufacturing and Supply Agreement with Pharmaserve (North West) Limited |
N/A |
25 Aug |
2017 Interim Results Announcement |
N/A |
02 Jun |
2017 Annual General Meeting |
|
28 Mar |
2016 Annual Results Announcement |
N/A |